default author photo

Jing Zeng

affiliation not provided to SSRN

  • affiliation not provided to SSRN

SCHOLARLY PAPERS

2

DOWNLOADS

68

TOTAL CITATIONS

0

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Early FDG PET imaging and circulating immune biomarkers of response and outcomes following chemotherapy and PD-1 checkpoint inhibitors in patients with stage IV NSCLC

Number of pages: 20 Posted: 08 Apr 2026
Faisal Yaseen, Rafael Santana-Davila, Daniel S. Hippe, Clemens Grassberger, Delphine L. Chen, Christina Baik, Keith D. Eaton, Diane Tseng, Smitha Patiyil Menon, Lei Deng, Sylvia M. Lee, Ariana D. Jimenez, Paul D. Lampe, A. McGarry Houghton, Paul E. Kinahan, Jing Zeng and Stephen R. Bowen
University of Washington, Swedish Medical Center - Swedish Cancer Institute, affiliation not provided to SSRN, University of Washington, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Washington, affiliation not provided to SSRN, University of Washington, affiliation not provided to SSRN and University of Washington
Downloads 36 (1,290,922)

Abstract:

Loading...

Non small cell lung cancer, Stage IV NSCLC, FDG PET CT, Chemoimmunotherapy, pembrolizumab, Liver SUVmax, Cytokines, T cell receptor diversity, Treatment response prediction, Overall survival, Progression free survival, Imaging biomarkers, Circulating immune biomarkers

2.

Hypofractionated and Stereotactic Body Proton Radiotherapy for a High-Risk Lung Cancer Cohort: A Multi-Institutional Experience from the Proton Collaborative Group Prospective Registry

Number of pages: 16 Posted: 22 Mar 2026
Alexander Allen, Charles B. Simone II, Kai Sun, David F. Alicia, Ajay Banskota, Gopal K. Bajaj, John H. Chang, James R. Gray, Ryan S. Grover, Christian Hyde, Jenna B. Jatczak, Kara E. Lehman, Mark McDonald, Stephen A. Mihalcik, Sina Mossahebi, Michelle R. Mundis Myers, Yosan G. Okbamichael, Stephanie M. Perkins, Robert H. Press, Zaker H. Rana, Lane R. Rosen, Ronny L. Rotondo, Christopher C. Sinesi, Henry K. Tsai, James J. Urbanic, Carlos Vargas, Nathan Y. Yu, Jing Zeng and Matthew J. Ferris
affiliation not provided to SSRN, Memorial Sloan Kettering Cancer Center - Department of Radiation Oncology, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Inova Health System, affiliation not provided to SSRN, Tennessee Oncology, affiliation not provided to SSRN, Karmanos Cancer Institute, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Alabama at Birmingham, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Kansas - University of Kansas Medical Center, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Mayo Clinic, affiliation not provided to SSRN and affiliation not provided to SSRN
Downloads 32 (1,332,057)

Abstract:

Loading...

Proton beam therapy, SBRT, moderately hypofractionated RT, Lung cancer, Non-small cell lung cancer, ablative radiotherapy, ultracentral, re-irradiation, Proton therapy, intensity-modulated proton therapy, pencil-beam scanning